400 IU of Vitamin D daily provided no benefit (UK RCT this time)

The effect of vitamin D3 supplementation on vitamin D status and associated health outcomes in children: a randomised controlled trial

J Nutr. 2026 Mar 24:101493. doi: 10.1016/j.tjnut.2026.101493.

Emily Royle 1, Dominique U Glatt 1, Emeir M McSorley 1, L Kirsty Pourshahidi 1, David J Armstrong 2, Laura Grimley 1, Mary M Slevin 1, Cealan O Henry 1, James E McMullan 1, R Revuelta Iniesta 3, Jane T McCluskey 4, Nigel Gleeson 4, Pamela J Magee 5

Background: Vitamin D is a key regulator of musculoskeletal growth, immune regulation and cognitive function in children. As children in the UK and Ireland are at risk of vitamin D deficiency due to the northern latitude, supplementation is recommended. To our knowledge, the effect of supplementation on status and related health outcomes has not been investigated in children residing in the UK/Ireland.

Objective: To examine the effect of vitamin D3 supplementation on vitamin D status, and related health outcomes in children.

Methods: The D-VinCHI study was a double-blind, randomised placebo-controlled trial, conducted among healthy children (aged 4-11 years). Children received 12 weeks of either 10μg/day vitamin D3 or a placebo devoid of vitamin D (control) in the form of an oral spray. The primary outcome, plasma 25-hydroxyvitamin D [25(OH)D], and secondary outcomes including grip strength, balance, cognitive function, winter status, immune markers and bone turnover markers were assessed pre- and post-intervention.

Results: 118 participants completed the study (mean age 8.1±1.8y; 51% girls). Supplementation significantly increased 25(OH)D concentration (from 66.31±17.26 to 69.04±16.93 nmol/L) compared to a decline in the placebo group (63.67±19.48 to 56.29±18.58 nmol/L; p<0.001) and prevented deficiency during the extended winter months. No effects were observed on muscle function, cognitive function, immune function or bone turnover markers.

Conclusion: Vitamin D insufficiency is prevalent in UK/Irish children and supplementation in the form of an oral spray is effective in achieving/maintaining an adequate status in most children. Further research is warranted to elucidate mechanisms underpinning non-response to supplementation and to further investigate the potential beneficial effects of supplementation on cognitive function. This trial was registered with ClinicalTrials.gov (NCT05018988: https://clinicaltrials.gov/study/NCT05018988).

PDF

Claude AI critique of this study

Summary: "400 IU of Vitamin D Daily Provided No Benefit" (UK RCT)

Study design: The D-VinCHI trial was a 12-week double-blind, placebo-controlled RCT conducted in healthy UK/Irish children aged 4–11. Children received either 10 µg/day (400 IU) of vitamin D3 via oral spray or a placebo.
Dose is the key problem: 400 IU barely moved the needle — supplemented children's 25(OH)D levels rose only marginally (66 → 69 nmol/L), while placebo children dropped meaningfully (64 → 56 nmol/L). The dose prevented decline but didn't achieve therapeutically meaningful levels.
No functional benefits observed: Despite modest improvement in vitamin D status, no statistically significant effects were found on muscle strength, balance, cognitive function, immune markers, or bone turnover — the headline "no benefit" result.
Deficiency is widespread: Vitamin D insufficiency was confirmed as prevalent among UK/Irish children, driven by the northern latitude limiting UVB exposure, particularly during extended winter months.
The real takeaway — dose, not vitamin D: VitaminDWiki's framing is critical: 400 IU is far below what most researchers consider a therapeutic dose. Studies repeatedly show that higher doses (1,000–4,000 IU) are needed to achieve serum levels associated with health outcomes. This trial essentially tested an inadequate dose.
UK policy context: The UK's SACN continues to recommend only 400 IU/day and targets a 25(OH)D threshold of just 25 nmol/L (10 ng/mL) — widely regarded as the lowest official recommendation in the world. UK guidelines lag behind evidence by design or institutional inertia.
Conflict of interest concern: A BMJ investigation found ~65% of UK government nutrition advisors have financial ties to food companies, raising questions about why recommendations remain so conservative.
Self-fulfilling policy failure: When doctors and patients use only 400 IU and see no benefit, they incorrectly conclude that "vitamin D doesn't work" — reinforcing a cycle of under-dosing, null results, and stalled guidelines.
Children especially at risk: UK infants and children are among the least likely in Europe to receive vitamin D supplementation, and political/policy action has been overdue for years.
Research gap acknowledged: The authors call for further study into non-response mechanisms and whether higher doses or longer durations would unlock benefits for cognitive and immune function — an implicit concession that this trial's design may have been underpowered by dose.

Related in VitaminDWiki

Doctors and patients experiencing only 400 IU mistakenly conclude that Vitamin D does not help